NAYA Therapeutics is a clinical-stage biopharmaceutical company dedicated to

pioneering the next generation of cancer immunotherapies.

​

We are building a best-in-class portfolio of immuno-oncology assets, 

leveraging the power of multifunctional antibodies and radioimmunotherapy

to establish new standards of care in hepatocellular carcinoma and multiple myeloma. 

​

​​

​​​ 

​